McKinsey Opioid Work Included Advising Distributors, Tribe Says
(Bloomberg) -- McKinsey & Co.'s role in assisting companies profiting from opioid-based painkillers was “far more extensive” than just advising makers of the highly addictive medicines, according to an Indian tribe's newly filed lawsuit.
Besides advising manufacturers such as Johnson & Johnson and Endo International Plc, the consulting firm helped distributors and retailers including McKesson Corp. find ways to sell more opioids, the Oklahoma-based Cherokee Nation said in its suit.
McKinsey said the claim is incorrect.
“These allegations are meritless,” D.J. Carella, a McKinsey spokesman, said Thursday in an emailed statement. “Our work with the pharmacies and distributors referenced in this complaint was longstanding and related to a range of business issues, and none of our work for these entities focused on opioids.”
McKinsey has become a target for tribes and U.S. cities and counties after it agreed to pay $641 million to states to settle claims over its opioid consulting work. But tribes and local governments are still suing McKinsey, saying they are being improperly denied a payout from the accord.
The firm says its payout to the states covers all legal claims stemming from the massive U.S. opioid litigation.
Read More: Burned in Tobacco Deal, Cities in Drug Fight Target McKinsey
The Cherokee Nation is the latest to sue McKinsey.
“McKinsey advised companies at every link in the opioid value chain, starting with their manufacture, to their distribution throughout the United States, and, finally, to their sale to consumers,” the tribe said in the suit, filed Wednesday in state court in Oklahoma.
Distributors such as McKesson hired McKinsey to handle tasks such as analyzing the process of “authorizing medication requests with insurance companies, a critical issue for the opioid industry,” the tribe said. AmerisourceBergen Corp. turned to McKinsey to study the company's “outreach to drug manufacturers,” according to the suit.
Representatives for McKesson and AmerisourceBergen didn't immediately respond to emails seeking comment on the tribe's suit. Neither company was named as a defendant in the case.
Read More: McKinsey's Nevada Opioid Deal Brings Payouts to $641 Million
The case is The Cherokee Nation v. McKinsey, No. CJ-21-76, District Court of Sequoyah County, Oklahoma.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.